Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2003 Aug;111(10):1335–1339. doi: 10.1289/ehp.6109

Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes.

Freya Kamel 1, David M Umbach 1, Teresa A Lehman 1, Lawrence P Park 1, Theodore L Munsat 1, Jeremy M Shefner 1, Dale P Sandler 1, Howard Hu 1, Jack A Taylor 1
PMCID: PMC1241615  PMID: 12896855

Abstract

Previous studies have suggested that lead exposure may be associated with increased risk of amyotrophic lateral sclerosis (ALS). Polymorphisms in the genes for delta-aminolevulinic acid dehydratase (ALAD) and the vitamin D receptor (VDR) may affect susceptibility to lead exposure. We used data from a case-control study conducted in New England from 1993 to 1996 to evaluate the relationship of ALS to polymorphisms in ALAD and VDR and the effect of these polymorphisms on the association of ALS with lead exposure. The ALAD 2 allele (177G to C; K59N) was associated with decreased lead levels in both patella and tibia, although not in blood, and with an imprecise increase in ALS risk [odds ratio (OR) = 1.9; 95% confidence interval (95% CI), 0.60-6.3]. We found a previously unreported polymorphism in ALAD at an Msp1 site in intron 2 (IVS2+299G>A) that was associated with decreased bone lead levels and with an imprecise decrease in ALS risk (OR = 0.35; 95% CI, 0.10-1.2). The VDR B allele was not associated with lead levels or ALS risk. Our ability to observe effects of genotype on associations of ALS with occupational exposure to lead or with blood or bone lead levels was limited. These findings suggest that genetic susceptibility conferred by polymorphisms in ALAD may affect ALS risk, possibly through a mechanism related to internal lead exposure.

Full Text

The Full Text of this article is available as a PDF (147.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Chalabi A., Leigh P. N. Recent advances in amyotrophic lateral sclerosis. Curr Opin Neurol. 2000 Aug;13(4):397–405. doi: 10.1097/00019052-200008000-00006. [DOI] [PubMed] [Google Scholar]
  2. Alexander B. H., Checkoway H., Costa-Mallen P., Faustman E. M., Woods J. S., Kelsey K. T., van Netten C., Costa L. G. Interaction of blood lead and delta-aminolevulinic acid dehydratase genotype on markers of heme synthesis and sperm production in lead smelter workers. Environ Health Perspect. 1998 Apr;106(4):213–216. doi: 10.1289/ehp.98106213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aro A. C., Todd A. C., Amarasiriwardena C., Hu H. Improvements in the calibration of 109Cd K x-ray fluorescence systems for measuring bone lead in vivo. Phys Med Biol. 1994 Dec;39(12):2263–2271. doi: 10.1088/0031-9155/39/12/009. [DOI] [PubMed] [Google Scholar]
  4. Bellinger D., Hu H., Titlebaum L., Needleman H. L. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health. 1994 Mar-Apr;49(2):98–105. doi: 10.1080/00039896.1994.9937461. [DOI] [PubMed] [Google Scholar]
  5. Bergdahl I. A., Gerhardsson L., Schütz A., Desnick R. J., Wetmur J. G., Skerfving S. Delta-aminolevulinic acid dehydratase polymorphism: influence on lead levels and kidney function in humans. Arch Environ Health. 1997 Mar-Apr;52(2):91–96. doi: 10.1080/00039899709602870. [DOI] [PubMed] [Google Scholar]
  6. Bergdahl I. A., Grubb A., Schütz A., Desnick R. J., Wetmur J. G., Sassa S., Skerfving S. Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol. 1997 Oct;81(4):153–158. doi: 10.1111/j.1600-0773.1997.tb02061.x. [DOI] [PubMed] [Google Scholar]
  7. Brooks B. R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci. 1994 Jul;124 (Suppl):96–107. doi: 10.1016/0022-510x(94)90191-0. [DOI] [PubMed] [Google Scholar]
  8. Burger D. E., Milder F. L., Morsillo P. R., Adams B. B., Hu H. Automated bone lead analysis by K-x-ray fluorescence for the clinical environment. Basic Life Sci. 1990;55:287–292. doi: 10.1007/978-1-4613-1473-8_39. [DOI] [PubMed] [Google Scholar]
  9. Cooper G. S., Umbach D. M. Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res. 1996 Dec;11(12):1841–1849. doi: 10.1002/jbmr.5650111203. [DOI] [PubMed] [Google Scholar]
  10. Fleming D. E., Chettle D. R., Wetmur J. G., Desnick R. J., Robin J. P., Boulay D., Richard N. S., Gordon C. L., Webber C. E. Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers. Environ Res. 1998 Apr;77(1):49–61. doi: 10.1006/enrs.1997.3818. [DOI] [PubMed] [Google Scholar]
  11. Fullmer C. S. Intestinal interactions of lead and calcium. Neurotoxicology. 1992 Winter;13(4):799–807. [PubMed] [Google Scholar]
  12. Hsieh L. L., Liou S. H., Chen Y. H., Tsai L. C., Yang T., Wu T. N. Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. J Occup Environ Med. 2000 Feb;42(2):151–155. doi: 10.1097/00043764-200002000-00009. [DOI] [PubMed] [Google Scholar]
  13. Hu H., Rabinowitz M., Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998 Jan;106(1):1–8. doi: 10.1289/ehp.981061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hu H., Wu M. T., Cheng Y., Sparrow D., Weiss S., Kelsey K. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect. 2001 Aug;109(8):827–832. doi: 10.1289/ehp.01109827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kamel Freya, Umbach David M., Munsat Theodore L., Shefner Jeremy M., Hu Howard, Sandler Dale P. Lead exposure and amyotrophic lateral sclerosis. Epidemiology. 2002 May;13(3):311–319. doi: 10.1097/00001648-200205000-00012. [DOI] [PubMed] [Google Scholar]
  16. Kelada S. N., Shelton E., Kaufmann R. B., Khoury M. J. Delta-aminolevulinic acid dehydratase genotype and lead toxicity: a HuGE review. Am J Epidemiol. 2001 Jul 1;154(1):1–13. doi: 10.1093/aje/154.1.1. [DOI] [PubMed] [Google Scholar]
  17. Lee B. K., Lee G. S., Stewart W. F., Ahn K. D., Simon D., Kelsey K. T., Todd A. C., Schwartz B. S. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2001 Apr;109(4):383–389. doi: 10.1289/ehp.01109383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lee S. S., Lee B. K., Lee G. S., Stewart W. F., Simon D., Kelsey K., Todd A. C., Schwartz B. S. Associations of lead biomarkers and delta-aminolevulinic acid dehydratase and vitamin D receptor genotypes with hematopoietic outcomes in Korean lead workers. Scand J Work Environ Health. 2001 Dec;27(6):402–411. doi: 10.5271/sjweh.633. [DOI] [PubMed] [Google Scholar]
  19. Lehman T. A., Haffty B. G., Carbone C. J., Bishop L. R., Gumbs A. A., Krishnan S., Shields P. G., Modali R., Turner B. C. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res. 2000 Feb 15;60(4):1062–1069. [PubMed] [Google Scholar]
  20. Longnecker M. P., Kamel F., Umbach D. M., Munsat T. L., Shefner J. M., Lansdell L. W., Sandler D. P. Dietary intake of calcium, magnesium and antioxidants in relation to risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2000 Jul-Aug;19(4):210–216. doi: 10.1159/000026258. [DOI] [PubMed] [Google Scholar]
  21. Morrison N. A., Qi J. C., Tokita A., Kelly P. J., Crofts L., Nguyen T. V., Sambrook P. N., Eisman J. A. Prediction of bone density from vitamin D receptor alleles. Nature. 1994 Jan 20;367(6460):284–287. doi: 10.1038/367284a0. [DOI] [PubMed] [Google Scholar]
  22. Nelson L. M. Epidemiology of ALS. Clin Neurosci. 1995;3(6):327–331. [PubMed] [Google Scholar]
  23. Schwartz B. S., Lee B. K., Lee G. S., Stewart W. F., Simon D., Kelsey K., Todd A. C. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2000 Oct;108(10):949–954. doi: 10.1289/ehp.00108949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schwartz B. S., Lee B. K., Stewart W., Ahn K. D., Springer K., Kelsey K. Associations of delta-aminolevulinic acid dehydratase genotype with plant, exposure duration, and blood lead and zinc protoporphyrin levels in Korean lead workers. Am J Epidemiol. 1995 Oct 1;142(7):738–745. doi: 10.1093/oxfordjournals.aje.a117705. [DOI] [PubMed] [Google Scholar]
  25. Schwartz B. S., Lee B. K., Stewart W., Sithisarankul P., Strickland P. T., Ahn K. D., Kelsey K. delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid. Occup Environ Med. 1997 Apr;54(4):241–246. doi: 10.1136/oem.54.4.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schwartz B. S., Stewart W. F., Kelsey K. T., Simon D., Park S., Links J. M., Todd A. C. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect. 2000 Mar;108(3):199–203. doi: 10.1289/ehp.00108199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sithisarankul P., Schwartz B. S., Lee B. K., Kelsey K. T., Strickland P. T. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin, 5-aminolevulinic acid, in lead-exposed workers. Am J Ind Med. 1997 Jul;32(1):15–20. doi: 10.1002/(sici)1097-0274(199707)32:1<15::aid-ajim2>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  28. Smith C. M., Hu H., Wang X., Kelsey K. T. ALA-D genotype is not associated with HT or HB levels among workers exposed to low levels of lead. Med Lav. 1995 May-Jun;86(3):229–235. [PubMed] [Google Scholar]
  29. Smith C. M., Wang X., Hu H., Kelsey K. T. A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead. Environ Health Perspect. 1995 Mar;103(3):248–253. doi: 10.1289/ehp.95103248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wetmur J. G., Kaya A. H., Plewinska M., Desnick R. J. Molecular characterization of the human delta-aminolevulinate dehydratase 2 (ALAD2) allele: implications for molecular screening of individuals for genetic susceptibility to lead poisoning. Am J Hum Genet. 1991 Oct;49(4):757–763. [PMC free article] [PubMed] [Google Scholar]
  31. Wetmur J. G., Lehnert G., Desnick R. J. The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res. 1991 Dec;56(2):109–119. doi: 10.1016/s0013-9351(05)80001-5. [DOI] [PubMed] [Google Scholar]
  32. Wu Ming-Tsang, Kelsey Karl, Schwartz Joel, Sparrow David, Weiss Scott, Hu Howard. A delta-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the normative aging study. Environ Health Perspect. 2003 Mar;111(3):335–341. doi: 10.1289/ehp.5504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ziemsen B., Angerer J., Lehnert G., Benkmann H. G., Goedde H. W. Polymorphism of delta-aminolevulinic acid dehydratase in lead-exposed workers. Int Arch Occup Environ Health. 1986;58(3):245–247. doi: 10.1007/BF00432107. [DOI] [PubMed] [Google Scholar]
  34. Zmuda J. M., Cauley J. A., Ferrell R. E. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000;22(2):203–217. doi: 10.1093/oxfordjournals.epirev.a018033. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES